Trial · NCT00634920
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1 - Pre-Randomization | STARTED | Everolimus (CNI-free) | 0 | |
| Period 1 - Pre-Randomization | STARTED | Control (CsA) | 0 | |
| Period 1 - Pre-Randomization | STARTED | Pre-Randomized Patients | 341 | |
| Period 1 - Pre-Randomization | COMPLETED | Everolimus (CNI-free) | 0 | |
| Period 1 - Pre-Randomization | COMPLETED | Control (CsA) | 0 | |
| Period 1 - Pre-Randomization | COMPLETED | Pre-Randomized Patients | 204 | |
| Period 1 - Pre-Randomization | NOT COMPLETED | Everolimus (CNI-free) | 0 | |
| Period 1 - Pre-Randomization | NOT COMPLETED | Control (CsA) | 0 | |
| Period 1 - Pre-Randomization | NOT COMPLETED | Pre-Randomized Patients | 137 | |
| Period 2 - Post-Randomization | STARTED | Everolimus (CNI-free) | 104 | |
| Period 2 - Post-Randomization | STARTED | Control (CsA) | 100 | |
| Period 2 - Post-Randomization | STARTED | Pre-Randomized Patients | 0 | |
| Period 2 - Post-Randomization | Full Analysis Set (FAS) | Everolimus (CNI-free) | 92 | |
| Period 2 - Post-Randomization | Full Analysis Set (FAS) | Control (CsA) | 90 | |
| Period 2 - Post-Randomization | Full Analysis Set (FAS) | Pre-Randomized Patients | 0 | |
| Period 2 - Post-Randomization | COMPLETED | Everolimus (CNI-free) | 43 | |
| Period 2 - Post-Randomization | COMPLETED | Control (CsA) | 68 | |
| Period 2 - Post-Randomization | COMPLETED | Pre-Randomized Patients | 0 | |
| Period 2 - Post-Randomization | NOT COMPLETED | Everolimus (CNI-free) | 61 | |
| Period 2 - Post-Randomization | NOT COMPLETED | Control (CsA) | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00634920/flow